The Department of Health and Human Services has issued a request for information as it considers a new "biovigilance" initiative to assure safety of the nation's supply of blood, blood components, tissues, cells and organs.
HHS seeks information on a number of issues related to development of a public-private partnership to identify risks and mitigation strategies. These issues include strategies to reduce medical errors, improve reporting and analyzing of adverse events, identify emerging infectious disease prevalence in donors and recipients, and identify requirements for new data repositories and data quality and measurement.
The public-private partnership would include participation from academia, philanthropic groups, patient advocates, blood banks, manufacturers, transplant centers and professional societies, among others. More information is available in a notice published April 25 in the Federal Register.
Register or login for access to this item and much more
All Health Data Management content is archived after seven days.
Community members receive:
- All recent and archived articles
- Conference offers and updates
- A full menu of enewsletter options
- Web seminars, white papers, ebooks
Already have an account? Log In
Don't have an account? Register for Free Unlimited Access